Summary
Updated Aug 30, 2026
James A. Bianco is Chief Executive Officer of Kintara Therapeutics, Inc. (HURA). 5 SEC Form 4 filings on record going back to 2024, most recently on 29 May 2026.
Recent Transactions
2Every recent SEC Form 4 transaction James A. Bianco has reported, most recent first.
Most Active Insiders Right Now
James A. Bianco has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- David N. Capobianco - $177.14M of WBI open-market activity in the last 90 days
- Insight Holdings Group, LLC - $174.75M of HNGE open-market activity in the last 90 days
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 90 days
- KL Pattern Holdings LP - $166.93M of PTRN open-market activity in the last 90 days
- Silver Lake Partners V DE (AIV), L.P. - $165.05M of DELL open-market activity in the last 90 days
- GIC Private Ltd - $158.25M of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James A. Bianco?
James A. Bianco is a corporate insider, tracked as Chief Executive Officer of Kintara Therapeutics, Inc. (HURA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James A. Bianco last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 5 filings going back to 2024.
Where can I see all of James A. Bianco's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James A. Bianco and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
